Examples of 'refer to the summary' in a sentence
Meaning of "refer to the summary"
This phrase suggests looking at or consulting a summary of information or details that have been previously provided or written. It implies that the necessary information can be found in a concise summary instead of searching through a detailed document or discussion
How to use "refer to the summary" in a sentence
Basic
Advanced
refer to the summary
Please refer to the summary of the legislative changes for more information.
Patients receiving ribavirin should also refer to the Summary of Product Characteristics of ribavirin.
Refer to the Summary for the relevant time limits.
For patients coadministered ribavirin refer to the Summary of Product Characteristics of ribavirin.
Refer to the Summary of.
For departmental breakdown refer to the Summary of Changes to Voted Appropriations.
Refer to the Summary of Product Characteristics of dasabuvir for its pharmacological properties.
For more details, please refer to the summary of results in the following page.
Refer to the Summary of Product Characteristics for the medicinal product containing maraviroc.
For patients co - administered ribavirin refer to the Summary of Product Characteristics of ribavirin.
Please refer to the Summary of Product Characteristics for information on the posology.
For interactions with ombitasvir / paritaprevir / ritonavir refer to the Summary of Product Characteristics.
Refer to the Summary of Product Characteristics of the particular generator for more information.
For further information, physicians should refer to the Summary of Product Characteristics for atazanavir.
Refer to the Summary of Product Characteristics for peginterferon alfa and ribavirin which must be.
See also
For further information, physicians should refer to the Summary of Product Characteristics for fosamprenavir.
Refer to the Summary of Product Characteristics for ribavirin and peginterferon alpha for additional.
For further information, physicians should refer to the Summary of Product Characteristics for tipranavir.
Refer to the Summary of Product Characteristics of other antiretroviral medicinal products for dosing information.
For further information, physicians should refer to the Summary of Product Characteristics for amprenavir.
Refer to the Summary of Product Characteristics for peginterferon alfa and ribavirin for additional.
For further information, physicians should refer to the Summary of Product Characteristics for saquinavir.
Refer to the Summary of Product Characteristics of ribavirin.
For details regarding trastuzumab, please refer to the summary of product characteristics ( SmPC ).
Please refer to the Summary of Product Characteristics of fulvestrant.
A specific reversal agent ( Praxbind ® ) is available please refer to the Summary of Product.
Healthcare professionals should refer to the Summary of Product Characteristics for full prescribing information.
Refer to the Summary of Product Characteristics of thalidomide for additional information.
For contra-indications with ombitasvir/ paritaprevir /ritonavir refer to the Summary of Product Characteristics.
Please refer to the Summary of Product Characteristics for melphalan.
SOLUTION 2, If you are comparing plans, refer to the Summary of Benefits.
Please refer to the Summary of Product Characteristics before prescribing.
For further information, refer to the Summary of Product Characteristics for darunavir.
Refer to the Summary of Product Characteristics of rituximab for more information.
For further information, refer to the Summary of Product Characteristics for maraviroc.
Refer to the Summary of Product Characteristics for ribavirin for additional information.
Important, Please refer to the Summary of Product Characteristics before prescribing.
Refer to the Summary of Product Characteristics for atazanavir for further details.
For further information, refer to the Summary of Product Characteristics for Prezista.
Please refer to the Summary of Product Characteristics for these medicinal products.
For further information, refer to the Summary of Product Characteristics for Celsentri.
Please refer to the Summary of Product Characteristics for full prescribing information.
Please refer to the Summary of Product Characteristics for fosaprepitant.
Please refer to the Summary of Product Characteristics of the powder formulation.
Please refer to the Summary of Product Characteristics for peginterferon alfa.
Refer to the summary of comments for strong acids and bases in section A1 above.
Refer to the Summary of Product Characteristics of tezacaftor / ivacaftor for additional data.
Refer to the Summary of Product Characteristics for elbasvir / grazoprevir for more information.
Please refer to the Summary of Product Characteristics of co-administered antiemetics.
Please refer to the Summary of Product Characteristics of co-administered antiemetic agents.
You'll also be interested in:
Examples of using Refer
Show more
Refer to the instruction manual of the remote
Timeliness can refer to two distinct phenomena
Refer to the instructions from the manufacturer
Examples of using Summary
Show more
Summary information relevant to the risk profile
We give a brief summary of these two documents
Summary of the evaluation of the master plan
